Physician profile
Sameer H Khan
NPI 1134101439
$5,000.14
in general payments reported to CMS, 2019-2025
16 companies · $699 in 2025
The $699 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,554 · 2020: $248 · 2021: $547 · 2022: $951 · 2023: $897 · 2024: $104 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,699.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,367.29 | 2019-2025 | Clareon, Clareon Panoptix Pro, Argos |
| Glaukos Corporation | $1,200.66 | 2019-2025 | Idosetr, Istent Infinite |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $835.89 | 2019-2021 | |
| Allergan, INC. | $398.60 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $373.38 | 2022-2025 | Xiidra, Miebo |
| Johnson & Johnson Surgical Vision, INC. | $227.26 | 2019-2023 | Lipiflow System Activator (Disposable) |
| Harrow Eye, LLC | $124.72 | 2023 | Iheezo |
| Rxsight INC | $124.69 | 2022-2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Sun Pharmaceutical Industries INC. | $78.43 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $72.10 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $65.65 | 2025 | Xdemvy |
| Abbvie INC. | $46.75 | 2025 | |
| Oyster Point Pharma, INC. | $24.69 | 2022 | |
| Kala Pharmaceuticals, INC. | $24.13 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $16.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.